Fcγ receptor IIIb (CD16b) polymorphisms are associated with susceptibility to idiopathic pulmonary fibrosis

Lung

Volumn 188, Issue 6, 2010, Pages 475-481

  Bournazos, Stylianos ^a,b   Bournazou, Irini ^a   Murchison, John T ^c   Wallace, William A ^a,c   McFarlane, Pauline ^c   Hirani, Nikhil ^a,c   Simpson, A John ^a,c   Dransfield, Ian ^a   Hart, Simon P ^d  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^d UNIVERSITY OF HULL   (United Kingdom)

Author keywords

Fc receptors; Idiopathic pulmonary fibrosis; Interstitial lung disease; Neutrophils

Indexed keywords

FC GAMMA RECEPTOR IIIB; GENOMIC DNA; LYMPHOCYTE ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FIBROSING ALVEOLITIS; FLOW CYTOMETRY; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; LUNG BIOPSY; LUNG FUNCTION TEST; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TOTAL LUNG CAPACITY;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DISEASE PROGRESSION; FEMALE; FORCED EXPIRATORY VOLUME; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GPI-LINKED PROTEINS; HETEROZYGOTE; HOMOZYGOTE; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; LUNG; MALE; MIDDLE AGED; ODDS RATIO; PHENOTYPE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PULMONARY DIFFUSING CAPACITY; RECEPTORS, IGG; RISK ASSESSMENT; RISK FACTORS; SCOTLAND; TOTAL LUNG CAPACITY; VITAL CAPACITY;

EID: 78651275153     PISSN: 03412040     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00408-010-9262-3     Document Type: Article

References (43)

1. KR Flaherty WD Travis TV Colby GB Toews EA Kazerooni BH Gross A Jain RL Strawderman A Flint JP Lynch FJ Martinez 2001 Histopathologic variability in usual and nonspecific interstitial pneumonias Am J Respir Crit Care Med 164 1722 1727 1:STN:280:DC%2BD38zgsVeqtA%3D%3D 11719316
2. B Bellon JF Bernaudin C Mandet B Chamak J Kuhn P Druet 1982 Immune complex-mediated lung injury produced by horseradish peroxidase (HRP) and anti-HRP antibodies in rats Am J Pathol 107 16 24 1:STN:280:DyaL387lslClsQ%3D%3D 7039334
3. PA Ward 1979 Immune complex injury of the lung Am J Pathol 97 85 92 1:CAS:528:DyaL3MXkvFGhsbg%3D 158982
4. WA Wallace SN Roberts H Caldwell E Thornton AP Greening D Lamb SE Howie 1994 Circulating antibodies to lung protein(s) in patients with cryptogenic fibrosing alveolitis Thorax 49 218 224 1:STN:280:DyaK2c3mt1Sisg%3D%3D 10.1136/thx.49.3.218 8202877
5. PP Dall'Aglio A Pesci G Bertorelli E Brianti S Scarpa 1988 Study of immune complexes in bronchoalveolar lavage fluids Respiration 54 Suppl 1 36 41 10.1159/000195495 3231904
6. RB Dreisin MI Schwarz AN Theofilopoulos RE Stanford 1978 Circulating immune complexes in the idiopathic interstitial pneumonias N Engl J Med 298 353 357 1:CAS:528:DyaE1cXhtF2gsLY%3D 10.1056/NEJM197802162980701 146160
7. AF Gelb RB Dreisen JD Epstein JD Silverthorne Y Bickel M Fields WA Border CR Taylor 1983 Immune complexes, gallium lung scans, and bronchoalveolar lavage in idiopathic interstitial pneumonitis-fibrosis Chest 84 148 153 1:STN:280:DyaL3s3mtVOnsw%3D%3D 10.1378/chest.84.2.148 6872593
8. PL Haslam B Thompson I Mohammed PJ Townsend ME Hodson EJ Holborow M Turner-Warwick 1979 Circulating immune complexes in patients with cryptogenic fibrosing alveolitis Clin Exp Immunol 37 381 390 1:STN:280: DyaL3c%2FmslOltg%3D%3D 315841
9. Y Martinet PL Haslam M Turner-Warwick 1984 Clinical significance of circulating immune complexes in 'lone' cryptogenic fibrosing alveolitis and those with associated connective tissue disorders Clin Allergy 14 491 497 1:STN:280:DyaL2M%2FisFertQ%3D%3D 10.1111/j.1365-2222.1984.tb02233.x 6333299
10. N Dobashi J Fujita M Murota Y Ohtsuki I Yamadori T Yoshinouchi R Ueda S Bandoh T Kamei M Nishioka T Ishida J Takahara 2000 Elevation of anti-cytokeratin 18 antibody and circulating cytokeratin 18: anti-cytokeratin 18 antibody immune complexes in sera of patients with idiopathic pulmonary fibrosis Lung 178 171 179 1:CAS:528:DC%2BD3cXlsFWju7k%3D 10.1007/s004080000020 10871435
11. N Dobashi J Fujita Y Ohtsuki I Yamadori T Yoshinouchi T Kamei M Tokuda S Hojo S Bandou Y Ueda J Takahara 2000 Circulating cytokeratin 8:anti-cytokeratin 8 antibody immune complexes in sera of patients with pulmonary fibrosis Respiration 67 397 401 1:CAS:528:DC%2BD3cXmtlSmt7k%3D 10.1159/000029537 10940793
12. T Takahashi I Wada Y Ohtsuka M Munakata Y Homma Y Kuroki 2007 Autoantibody to alanyl-tRNA synthetase in patients with idiopathic pulmonary fibrosis Respirology 12 642 653 10.1111/j.1440-1843.2007.01140.x 17875050 (Pubitemid 47414894)
13. J Gadek G Hunninghake R Zimmerman J Kelman J Fulmer RG Crystal 1979 Pathogenetic studies in idiopathic pulmonary fibrosis. Control of neutrophil migration by immune complexes Chest 75 264 265 1:STN:280:DyaE1M7mvVGitg%3D%3D 155510
14. GW Hunninghake JE Gadek TJ Lawley RG Crystal 1981 Mechanisms of neutrophil accumulation in the lungs of patients with idiopathic pulmonary fibrosis J Clin Invest 68 259 269 1:STN:280:DyaL3M3ktVWjsQ%3D%3D 10.1172/JCI110242 7251862
15. B Bradley HM Branley JJ Egan MS Greaves DM Hansell NK Harrison N Hirani R Hubbard F Lake AB Millar WAH Wallace AU Wells MK Whyte ML Wilsher 2008 Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society Thorax 63 Suppl 5 v1 v58 18757459
16. American Thoracic Society, European Respiratory Society 2002 American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001 Am J Respir Crit Care Med 165 277 304
17. S Bournazos SP Hart LH Chamberlain MJ Glennie I Dransfield 2009 Association of FcγRIIa (CD32a) with lipid rafts regulates ligand binding activity J Immunol 182 8026 8036 1:CAS:528:DC%2BD1MXmslCntb0%3D 10.4049/jimmunol.0900107 19494328
18. JM Green AD Schreiber EJ Brown 1997 Role for a glycan phosphoinositol anchor in Fcγ receptor synergy J Cell Biol 139 1209 1217 1:CAS:528:DyaK2sXnvFeqsL4%3D 10.1083/jcb.139.5.1209 9382867 (Pubitemid 27523208)
19. C Nathan 2006 Neutrophils and immunity: challenges and opportunities Nat Rev Immunol 6 173 182 1:CAS:528:DC%2BD28Xhsleltb8%3D 10.1038/nri1785 16498448 (Pubitemid 43290987)
20. S Bournazos JM Woof SP Hart I Dransfield 2009 Functional and clinical consequences of Fc receptor polymorphic and copy number variants Clin Exp Immunol 157 244 254 1:CAS:528:DC%2BD1MXhtVSntb%2FE 10.1111/j.1365-2249.2009. 03980.x 19604264
21. JE Salmon JC Edberg RP Kimberly 1990 Fcγ receptor III on human neutrophils. Allelic variants have functionally distinct capacities J Clin Invest 85 1287 1295 1:CAS:528:DyaK3cXitFCqtbk%3D 10.1172/JCI114566 1690757
22. PA Ory MR Clark EE Kwoh SB Clarkson IM Goldstein 1989 Sequences of complementary DNAs that encode the NA1 and NA2 forms of Fc receptor III on human neutrophils J Clin Invest 84 1688 1691 1:CAS:528:DyaL1MXmt1Kmsr4%3D 10.1172/JCI114350 2478590
23. PA Ory MR Clark AS Talhouk IM Goldstein 1991 Transfected NA1 and NA2 forms of human neutrophil Fc receptor III exhibit antigenic and structural heterogeneity Blood 77 2682 2687 1:CAS:528:DyaK3MXltFagt7o%3D 1710518
24. M De Haas M Kleijer R van Zwieten D Roos AE von dem Borne 1995 Neutrophil FcγRIIIb deficiency, nature, and clinical consequences: a study of 21 individuals from 14 families Blood 86 2403 2413 7662988
25. S Bournazos J Rennie S Hart KAA Fox I Dransfield 2008 Monocyte functional responsiveness after PSGL-1-mediated platelet adhesion is dependent on platelet activation status Arterioscler Thromb Vasc Biol 28 1491 1498 1:CAS:528:DC%2BD1cXosVeru78%3D 10.1161/ATVBAHA.108.167601 18497306
26. ML Trounstine GA Peltz H Yssel TW Huizinga AE Von dem Borne H Spits KW Moore 1990 Reactivity of cloned, expressed human FcγRIII isoforms with monoclonal antibodies which distinguish cell-type-specific and allelic forms of FcγRIII Int Immunol 2 303 310 1:STN:280:DyaK3M7itVGhtQ%3D%3D 10.1093/intimm/2.4.303 1703781
27. D Hanson RH Winterbauer SH Kirtland R Wu 1995 Changes in pulmonary function test results after 1 year of therapy as predictors of survival in patients with idiopathic pulmonary fibrosis Chest 108 305 310 1:STN:280:DyaK2MzmtFGlsw%3D%3D 10.1378/chest.108.2.305 7634857
28. PI Latsi RM du Bois AG Nicholson TV Colby D Bisirtzoglou A Nikolakopoulou S Veeraraghavan DM Hansell AU Wells 2003 Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends Am J Respir Crit Care Med 168 531 537 10.1164/rccm.200210-1245OC 12791580 (Pubitemid 37088594)
29. KR Flaherty JA Mumford S Murray EA Kazerooni BH Gross TV Colby WD Travis A Flint GB Toews JP Lynch FJ Martinez 2003 Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia Am J Respir Crit Care Med 168 543 548 10.1164/rccm.200209-1112OC 12773329 (Pubitemid 37088596)
30. SJ Weiss 1989 Tissue destruction by neutrophils N Engl J Med 320 365 376 1:CAS:528:DyaL1MXhtleiu7Y%3D 10.1056/NEJM198902093200606 2536474
31. JV Ravetch S Bolland 2001 IgG Fc receptors Annu Rev Immunol 19 275 290 1:CAS:528:DC%2BD3MXivFKgur4%3D 10.1146/annurev.immunol.19.1.275 11244038 (Pubitemid 32368037)
32. M Whyte R Hubbard R Meliconi M Whidborne V Eaton C Bingle J Timms G Duff A Facchini A Pacilli M Fabbri I Hall J Britton I Johnston F Di Giovine 2000 Increased risk of fibrosing alveolitis associated with interleukin-1 receptor antagonist and tumor necrosis factor-α gene polymorphisms Am J Respir Crit Care Med 162 755 758 1:STN:280:DC%2BD3cvjtlCmuw%3D%3D 10934117
33. M Checa V Ruiz M Montaño R Velázquez-Cruz M Selman A Pardo 2008 MMP-1 polymorphisms and the risk of idiopathic pulmonary fibrosis Hum Genet 124 465 472 1:CAS:528:DC%2BD1cXhsVCku77E 10.1007/s00439-008-0571-z 18853190
34. M Molina-Molina A Xaubet X Li A Abdul-Hafez K Friderici K Jernigan W Fu Q Ding J Pereda A Serrano-Mollar A Casanova E Rodríguez-Becerra F Morell J Ancochea C Picado BD Uhal 2008 Angiotensinogen gene G-6A polymorphism influences idiopathic pulmonary fibrosis disease progression Eur Respir J 32 1004 1008 1:CAS:528:DC%2BD1cXht1KqsbjE 10.1183/09031936.00015808 18508830
35. T Mushiroda S Wattanapokayakit A Takahashi T Nukiwa S Kudoh T Ogura H Taniguchi M Kubo N Kamatani Y Nakamura Group PCS 2008 A genome-wide association study identifies an association of a common variant in TERT with susceptibility to idiopathic pulmonary fibrosis J Med Genet 45 654 656 1:CAS:528: DC%2BD1cXhtlamtrvI 10.1136/jmg.2008.057356 18835860
36. P Pantelidis GC Fanning AU Wells KI Welsh RM Du Bois 2001 Analysis of tumor necrosis factor-α, lymphotoxin-α, tumor necrosis factor receptor II, and interleukin-6 polymorphisms in patients with idiopathic pulmonary fibrosis Am J Respir Crit Care Med 163 1432 1436 1:STN:280: DC%2BD3MzjsVOiug%3D%3D 11371414
37. RL Riha IA Yang GC Rabnott AM Tunnicliffe KM Fong PV Zimmerman 2004 Cytokine gene polymorphisms in idiopathic pulmonary fibrosis Intern Med J 34 126 129 1:CAS:528:DC%2BD2cXkt1Oitbw%3D 10.1111/j.1444-0903.2004.00503.x 15030461 (Pubitemid 38509996)
38. M Selman HM Lin M Montaño AL Jenkins A Estrada Z Lin G Wang SL DiAngelo X Guo TM Umstead CM Lang A Pardo DS Phelps J Floros 2003 Surfactant protein A and B genetic variants predispose to idiopathic pulmonary fibrosis Hum Genet 113 542 550 1:CAS:528:DC%2BD3sXot1Ors78%3D 10.1007/s00439-003-1015-4 13680361 (Pubitemid 37383769)
39. M Vasakova I Striz J Dutka A Slavcev S Jandova L Kolesar J Sulc 2007 Cytokine gene polymorphisms and high-resolution-computed tomography score in idiopathic pulmonary fibrosis Respir Med 101 944 950 10.1016/j.rmed.2006.09.013 17056243 (Pubitemid 46508680)
40. M Vasakova I Striz A Slavcev S Jandova L Kolesar J Sulc 2006 Th1/Th2 cytokine gene polymorphisms in patients with idiopathic pulmonary fibrosis Tissue Antigens 67 229 232 1:CAS:528:DC%2BD28XksFCms7k%3D 10.1111/j.1399-0039. 2006.00560.x 16573560 (Pubitemid 43383371)
41. HA Whittington RW Freeburn SIH Godinho J Egan Y Haider AB Millar 2003 Analysis of an IL-10 polymorphism in idiopathic pulmonary fibrosis Genes Immun 4 258 264 1:CAS:528:DC%2BD3sXjvFals7w%3D 10.1038/sj.gene.6363959 12761561 (Pubitemid 39562124)
42. A Xaubet A Marin-Arguedas S Lario J Ancochea F Morell J Ruiz-Manzano E Rodriguez-Becerra JM Rodriguez-Arias P Inigo S Sanz JM Campistol J Mullol C Picado 2003 Transforming growth factor-β1 gene polymorphisms are associated with disease progression in idiopathic pulmonary fibrosis Am J Respir Crit Care Med 168 431 435 10.1164/rccm.200210-1165OC 12746254 (Pubitemid 37046871)
43. M Zorzetto I Ferrarotti R Trisolini LL Agli R Scabini M Novo A De Silvestri M Patelli M Martinetti M Cuccia V Poletti E Pozzi M Luisetti 2003 Complement receptor 1 gene polymorphisms are associated with idiopathic pulmonary fibrosis Am J Respir Crit Care Med 168 330 334 10.1164/rccm.200302- 221OC 12773320 (Pubitemid 36974550)